Sort
85,873 grants matching “alzheimers”
Novel Mechanistic Targets of Steroid Hormones in the Brain
$1,128,969Meharvan Singh · University Of North Texas Hlth Sci Ctr · P01 · FY2014 · AG
ALZHEIMERS DISEASE PATIENT REGISTRY
$1,128,928Mayo Clinic Coll Of Medicine, Rochester · U01 · FY2002 · AG
Solvation modeling for next-gen biomolecule simulations
$1,128,699Kenneth A Dill · State University New York Stony Brook · RM1 · FY2021 · GM
Studying perceptual decision-making across cortex by combining population imaging, connectomics, and computational modeling
$1,128,678Christopher D Harvey · Harvard Medical School · R01 · FY2019 · NS
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
$1,128,467Mark H Tuszynski · University Of California, San Diego · R01 · FY2023 · AG
Microbial therapy improves gut permeability to reduce cognitive decline and Alzheimerâs disease
$1,128,405Hariom Yadav · University Of South Florida · RF1 · FY2021 · AG
Epidemiology of Brain Aging in the Very Old
$1,128,110Lon Ray White · Kuakini Medical Center · U01 · FY2011 · AG
Epidemiology of Brain Aging in the Very Old
$1,128,110Lon Ray White · Kuakini Medical Center · U01 · FY2011 · AG
Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimer's Disease
$1,127,955John Didsbury · T3d Therapeutics, Inc. · R44 · FY2015 · AG
IN VITRO AND IN VIVO MODELS OF ALZHEIMERS DISEASE
$1,127,952University Of Pennsylvania · P01 · FY2002 · AG
Systems Genetics Analysis of Resilience to Alzheimerâs disease
$1,127,343Catherine Cook Kaczorowski · Jackson Laboratory · R01 · FY2018 · AG
Administrative Core
$1,126,540Stephen M Strittmatter · Yale University · P30 · FY2025 · AG
Administration
$1,126,503John Morris · Washington University · U19 · FY2012 · AG
The Importance of Abnormal Inflammasome Activation as a Risk Factor between Traumatic Brain Injury and Alzheimerâs Disease
$1,126,479W. Dalton Dalton Dietrich · University Of Miami School Of Medicine · RF1 · FY2021 · NS
MITOCHONDRIAL DYSFUNCTION IN NEURODENEGENERATION/AGING
$1,126,239Winifred Masterson Burke Med Res Inst · P01 · FY2000 · AG
ANTECEDENT BIOMARKERS FOR AD: THE ADULT CHILDREN STUDY
$1,125,950John Morris · Washington University · P01 · FY2007 · AG
The impact of adverse interpersonal experiences (AIE) on mild cognitive impairment (MCI) and risk for Alzheimer's disease and related dementias (ADRD) in ethnically diverse twins
$1,125,947Robert F Krueger · University Of Minnesota · R01 · FY2023 · AG
Identification of the genetic and transcriptomic networks of cognitive and neuropathological resilience to Alzheimerâs disease associated viruses
$1,125,901Benjamin Readhead · Arizona State University-Tempe Campus · U01 · FY2018 · AG
Chaperome networks in Alzheimer's disease
$1,125,794Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2025 · AG
Small vessel disease biomarkers in a longitudinally-followed "stroke-belt" cohort
$1,125,772Donna M. Wilcock · University Of Kentucky · UH3 · FY2020 · NS
Models of Estrogen Interactions with Alzheimer Disease
$1,125,538University Of Southern California · P01 · FY2005 · AG
Statistical Methods for Alzheimer's Research
$1,125,535Bin Nan · University Of California-Irvine · RF1 · FY2022 · AG
Botanicals enhancing neurological and functional resilience in aging (BENFRA)
$1,125,413Amala Soumyanath · Oregon Health & Science University · U19 · FY2023 · AT
Boston University Alzheimer's Disease Core Center
$1,125,341Boston University Medical Campus · P30 · FY2003 · AG
Child and adult Metal exposures, gene expression and neuropathologically confirmed Alzheimer's Disease
$1,125,325Marc G Weisskopf · Harvard School Of Public Health · R56 · FY2023 · AG